KVOKAČKOVÁ, Barbora, Radek FEDR, Daniela KUŽÍLKOVÁ, Jan STUCHLÝ, Adéla VÁVROVÁ, Jiří NAVRÁTIL, Pavel FABIAN, Róbert ONDRUŠŠEK, Petra OVESNÁ, Ján REMŠÍK, Jan BOUCHAL, Tomáš KALINA and Karel SOUČEK. Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Molecular Oncology. Wiley, 2023, vol. 17, No 6, p. 1024-1040. ISSN 1574-7891. Available from: https://dx.doi.org/10.1002/1878-0261.13365.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
Authors KVOKAČKOVÁ, Barbora (703 Slovakia, belonging to the institution), Radek FEDR, Daniela KUŽÍLKOVÁ, Jan STUCHLÝ, Adéla VÁVROVÁ, Jiří NAVRÁTIL, Pavel FABIAN, Róbert ONDRUŠŠEK, Petra OVESNÁ (203 Czech Republic, belonging to the institution), Ján REMŠÍK, Jan BOUCHAL, Tomáš KALINA and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Molecular Oncology, Wiley, 2023, 1574-7891.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.600 in 2022
RIV identification code RIV/00216224:14310/23:00130413
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1002/1878-0261.13365
UT WoS 000926769000001
Keywords in English mass cytometry; phenotypic plasticity;single-cell profiles; triple-negative breastcancer; tumor heterogeneity; unsupervisedmachine learning algorithm
Tags 14119612, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 1/3/2024 12:57.
Abstract
Triple-negative breast cancer (TNBC) is an aggressive and complex subtype of breast cancer that lacks targeted therapy. TNBC manifests characteristic, extensive intratumoral heterogeneity that promotes disease progression and influences drug response. Single-cell techniques in combination with next-generation computation provide an unprecedented opportunity to identify molecular events with therapeutic potential. Here, we describe the generation of a comprehensive mass cytometry panel for multiparametric detection of 23 phenotypic markers and 13 signaling molecules. This single-cell proteomic approach allowed us to explore the landscape of TNBC heterogeneity, with particular emphasis on the tumor microenvironment. We prospectively profiled freshly resected tumors from 26 TNBC patients. These tumors contained phenotypically distinct subpopulations of cancer and stromal cells that were associated with the patient's clinical status at the time of surgery. We further classified the epithelial-mesenchymal plasticity of tumor cells, and molecularly defined phenotypically diverse populations of tumor-associated stroma. Furthermore, in a retrospective tissue-microarray TNBC cohort, we showed that the level of CD97 at the time of surgery has prognostic potential.
Links
EF16_025/0007381, research and development projectName: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
PrintDisplayed: 26/5/2024 10:45